Galectin Therapeutics

Norcross
37 Total Employees

Similar Companies Hiring

Pharmaceutical • Healthtech • Biotech • Big Data • Artificial Intelligence
New York, NY
140 Employees
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
19 Offices
121990 Employees
Healthtech • Logistics • Pharmaceutical
15 Offices
51000 Employees
Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin’s lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.

Galectin Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site:
Norcross, Georgia, USA